Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2228766/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2228766
Feb 20, 2024 - Investors are optimistic about ResMed's (RMD) increased adoption of AirSense10 and AirSense11 devices.
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 (Revised)
https://www.zacks.com/stock/news/2227458/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-revised?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2227458
Feb 16, 2024 - ResMed's (RMD) new AirCurve11 series incorporates MyAir and AirView digital health apps to provide maximum comfort and support during therapy.
0
ResMed (RMD) to Treat Sleep Apnea With New AirCurve 11 Device
https://www.zacks.com/stock/news/2225610/resmed-rmd-to-treat-sleep-apnea-with-new-aircurve-11-device?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2225610
Feb 13, 2024 - ResMed's (RMD) new AirCurve11 series incorporates myAir and AirView digital health apps to provide maximum comfort and support during therapy.
0
Why ResMed (RMD) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2221023/why-resmed-rmd-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2221023
Feb 05, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
0
ResMed (RMD) Q2 Earnings Beat Estimates, Margins Expand
https://www.zacks.com/stock/news/2216027/resmed-rmd-q2-earnings-beat-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2216027
Jan 25, 2024 - ResMed's (RMD) Q2 results reflect cost discipline to support an acceleration in profitability.
0
ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript
https://seekingalpha.com/article/4664838-resmed-inc-rmd-q2-2024-earnings-call-transcript?source=feed_sector_transcripts
Jan 24, 2024 - ResMed Inc. (NYSE:NYSE:RMD) Q2 2024 Earnings Conference Call January 24, 2024 4:30 PM ETCompany ParticipantsAmy Wakeham - Chief Communications and Investor...
0
ResMed (RMD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2215406/resmed-rmd-q2-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2215406
Jan 24, 2024 - While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
https://www.zacks.com/stock/news/2215273/resmed-rmd-tops-q2-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2215273
Jan 24, 2024 - ResMed (RMD) delivered earnings and revenue surprises of 3.87% and 0.46%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Stay Ahead of the Game With ResMed (RMD) Q2 Earnings: Wall Street's Insights on Key Metrics
https://www.zacks.com/stock/news/2213008/stay-ahead-of-the-game-with-resmed-rmd-q2-earnings-wall-street-s-insights-on-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213008
Jan 19, 2024 - Evaluate the expected performance of ResMed (RMD) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
0
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2211621/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2211621
Jan 17, 2024 - Investors are optimistic about ResMed (RMD) on strong uptake of the myAir app with AirSense11.
0
<Page 2